These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 6231146)
21. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Chaux P; Moutet M; Faivre J; Martin F; Martin M Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792 [TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients. Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546 [TBL] [Abstract][Full Text] [Related]
23. Reduced serum levels of a soluble form of the human adhesion receptor CD58 (LFA-3) in patients with inflammatory bowel disease. Hoffmann JC; Göke MN; Evers J; Räuker HJ; Bayer B; Manns MP Z Gastroenterol; 1996 Sep; 34(9):522-7. PubMed ID: 8873455 [TBL] [Abstract][Full Text] [Related]
25. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients. Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372 [TBL] [Abstract][Full Text] [Related]
26. [Selected cellular immunity parameters in patients with Lesniowski-Crohn disease]. Słotwiński R; Szczygieł B; Lech G; Kolewska D; Wasik M Pol Merkur Lekarski; 1997 Nov; 3(17):224-7. PubMed ID: 9523477 [TBL] [Abstract][Full Text] [Related]
27. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab. Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991 [TBL] [Abstract][Full Text] [Related]
28. Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer. Nakagoe T; Sawai T; Tsuji T; Jibiki M; Ohbatake M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H; Arisawa K J Exp Clin Cancer Res; 2001 Mar; 20(1):85-90. PubMed ID: 11370835 [TBL] [Abstract][Full Text] [Related]
29. [The effect of sera of breast cancer patients on NK cell activity]. Konjević G; Spuzić I Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436 [TBL] [Abstract][Full Text] [Related]
30. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease. Danis VA; Heatley RV Clin Exp Immunol; 1983 Dec; 54(3):739-46. PubMed ID: 6606515 [TBL] [Abstract][Full Text] [Related]
31. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210 [TBL] [Abstract][Full Text] [Related]
32. Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer. Saito T; Kuss I; Dworacki G; Gooding W; Johnson JT; Whiteside TL Clin Cancer Res; 1999 Jun; 5(6):1263-73. PubMed ID: 10389908 [TBL] [Abstract][Full Text] [Related]
33. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease. Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192 [TBL] [Abstract][Full Text] [Related]
34. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease. Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968 [TBL] [Abstract][Full Text] [Related]
35. The in vitro migration inhibition of mononuclear cells in patients with colorectal carcinoma. Kowalczyk D; Zembala M; Popiela T; Labza H Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):435-9. PubMed ID: 749793 [TBL] [Abstract][Full Text] [Related]
37. Mixed lymphocyte tumour cell whole blood microcultures in large bowel carcinoma patients. Lauder I; Bone G Clin Oncol; 1975 Dec; 1(4):321-7. PubMed ID: 129312 [No Abstract] [Full Text] [Related]
38. Comparison of the postoperative changes in the humoral and cellular immune activity in septic and non-septic colorectal cancer patients. Nagy A; Petri I; Baradnay G; Rasztik M; Mozga E; Zölley I; Karácsonyi S Acta Chir Hung; 1986; 27(4):195-202. PubMed ID: 3495948 [TBL] [Abstract][Full Text] [Related]
39. Proceedings: Inhibition of rosette-forming activity of lymphocytes in patients with large bowel cancer by a colorectal tumour extract. McIllmurray MB; Langman MJ Gut; 1974 Apr; 15(4):345. PubMed ID: 4546132 [No Abstract] [Full Text] [Related]
40. A study of lymph nodes draining colorectal cancer using a two-stage inhibition of leucocyte migration technique. Guillou PJ; Brennan TG; Giles GR Gut; 1975 Apr; 16(4):290-7. PubMed ID: 1132804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]